LONDON: Omega Diagnostics Group (LON:ODX)‘s stock had its “corporate” rating reiterated by stock analysts at FinnCap in a report issued on Tuesday.

ODX stock opened at GBX 13.25 ($0.17) on Tuesday. Omega Diagnostics Group has a 12 month low of GBX 15 ($0.20) and a 12 month high of GBX 28.01 ($0.37).

Omega Diagnostics Group PLC, through its subsidiaries, develops, manufactures, and distributes medical diagnostics products. The company operates in three segments: Allergy and Autoimmune, Food Intolerance, and Infectious Diseases and Other.

The Allergy and Autoimmune segment engages in the research, development, production, and marketing of in-vitro allergy and autoimmune tests used by doctors to diagnose patients with allergies and autoimmune diseases.